Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Repligen Corporation (RGEN)

NMS · Medical Instruments & Supplies

$145.34+14.28 (+10.90%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$7.11B
P/E (TTM)
142.49
EPS
$1.02
Div Yield
52W Range
$100.99–$175.77
Beta
1.06

Company overview

Next earnings: 2026-07-28(0d)

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Peers in Medical Instruments & Supplies

All in industry →

Recent press releases

Repligen Corporation has not issued a press release in this window.

SEC filings

All filings →

Repligen Corporation has not filed an SEC document in this window.

Repligen Corporation has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
6,619,271 sh+7.8%
1,064,000 sh● NEW
4,993,945 sh-1.0%
1,101,447 sh+159.6%
FMR LLC$469.9M
2,867,846 sh+6.6%
911,527 sh+154.3%
746,306 sh+241.4%

People at Repligen Corporation

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$169.1M
NI $5.8M
06/25
$182.4M
NI $14.9M
09/25
$188.8M
NI $14.9M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.26
Prior: $0.26
Revenue sparkline